Susan Browne, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Passage BIO, Inc. publishes a filing, an earnings call transcript or a press release.
Get PASG alertsAbout Susan Browne, Ph.D.
Passage BIO, Inc. reported in an 8-K filed August 1, 2024 that Susan Browne, Ph.D. was appointed Chief Scientific Officer, effective August 1, 2024. Passage BIO, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Passage BIO, Inc. includes Peter Smith, Ph.D. (CEO), William Chou (CEO and Board Member), William Chou, M.D. (CEO and Board Member) and 7 others.
“On August 1, 2024, the Company announced the appointments of Susan Browne, Ph.D. as Chief Scientific Officer of the Company and Stuart Henderson as Chief Business Officer of the Company, each effective as of August 1, 2024.”
Affiliation history
-
Passage BIO, Inc. (PASG)
SEC 8-K
Current2024-08-01–present
Company network
Leadership on record at Passage BIO, Inc.
- Peter Smith, Ph.D. CEO
- William Chou CEO, Board Member
- William Chou, M.D. CEO, Board Member
- Maxine Gowen Chairman
- Kathleen Borthwick CFO
- Athena Countouriotis Board Member
- Dolan Sondhi Board Member
- Dr. Maxine Gowen Board Member
- Dr. Michael Kamarck Board Member
- Thomas Kassberg Board Member